This is a preview of subscription content, log in via an institution to check access.
Reference
Huang N, et al. Case report: Successful treatment of advanced pulmonary sarcomatoid carcinoma with BUBIB-ALK rearrangement and KRAS G12C mutation by sintilimab combined with anlotinib. Frontiers in Oncology 14: Feb 2024. Available from: URL: https://dx.doi.org/10.3389/fonc.2024.1269148
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 2000, 48 (2024). https://doi.org/10.1007/s40278-024-54737-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-024-54737-x